EVMN
EVMN
NYSE · Biotechnology

Evommune Inc

$9.65
+0.28 (+2.99%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 15 83%
Hold 3 17%
Sell 0 0%
Price Target
Analyst Price Target +685.5% upside
Low Target $52.19
Average Target $75.80
High Target $91.23
Current Price $9.65
Current
$9.65
Target
$75.80
$52.19 $75.80 avg $91.23
Scenario Analysis
Bear Case
$52.19
440.8%
Low target
Base Case
$75.80
+685.5%
Avg target
Bull Case
$91.23
+845.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$33.20
-70.9% from high
52-Week Low
$9.30
+3.8% from low
Target vs 52W High
$75.80
+128.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%